Publications by authors named "C Spenle"

Claim this Profile
D
Disruption of Plexin-A1 signaling by FTX-101: mode of action and effect on oligodendrocyte biology.
Fabien Binamé, Kevin Leguay, Caroline Spenlé, Michaël Van Der Heyden, Oliver A Kent

Biomed Pharmacother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the MAtrix REgulating MOtif abolishes several hallmarks of cancer, triggering antitumor immunity.
Chengbei Li, Amanpreet Kaur, Alexia Pavlidaki, Caroline Spenlé, Irena Rajnpreht

Proc Natl Acad Sci U S A· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary strategies to be used in conjunction with animal models for multiple sclerosis drug discovery: adapting preclinical validation of drug candidates to the need of remyelinating strategies.
Imane Charmarke-Askar, Caroline Spenlé, Dominique Bagnard

Expert Opin Drug Discov· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorinated apelin-13 mediates neuroprotective effects in multiple sclerosis models.
Dafni Birmpili, Imane Charmarké-Askar, Caroline Spenlé, Stéphanie Riché, Lucas Dinh Pham-Van

Neurobiol Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of neuraminidase-1 sialidase activity by interfering peptides impairs insulin receptor activity in vitro and glucose homeostasis in vivo.
Kevin Toussaint, Aline Appert-Collin, Laetitia Vanalderwiert, Camille Bour, Christine Terryn

J Biol Chem· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis